Literature DB >> 8739519

The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis.

H Kruse1, M Hofshagen, S I Thoresen, W P Bredal, I Vollset, N E Søli.   

Abstract

In a retrospective study, 1538 strains of beta-haemolysin-producing Staphylococcus species isolated from dermatitis in dogs at three veterinary clinical microbiology laboratories in Norway during 1986-87 and 1993-94 were investigated for their antimicrobial susceptibility. None of the strains was resistant to cloxacillin, cephalexin or the quinolones enrofloxacin and ciprofloxacin. More than 96% of the strains were susceptible to trimethoprim-sulphonamide, bacitracin and fucidic acid. Between 67% and 89% of the strains were susceptible to erythromycin, lincosamides, tetracycline, neomycin and chloramphenicol. Only 37.9% of the strains were susceptible to penicillin. The frequency of penicillin resistance increased significantly between the first and second periods, from 46.0% to 58.6%. The frequency of resistance to lincomycin, clindamycin and erythromycin also increased significantly between the first and second periods, from 3.0%, 2.1% and 3.3% to 25.5%, 19.5% and 24.8%, respectively. A moderate increase in resistance to tetracycline was also noted, from 20.4% in the first to 27.6% in the second period. On the other hand, the frequency of resistance to trimethoprim-sulphonamide decreased significantly from 4.1% in the first to 0.9% in the second period. Many different resistance patterns were observed in each period. However, the proportion of multiresistant strains increased from 2.1% in the first to 10.2% in the second period. There was a decrease in resistance to the combination of trimethoprim-sulphonamide and penicillin from the first to the second period. Resistance to the combination of lincosamides and penicillin increased. For the combinations penicillin-tetracycline-lincosamides, penicillin-lincosamides-erythromycin, and penicillin-tetracycline-lincosamides-erythromycin, there was a striking increase in resistance between the first and the second periods.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739519     DOI: 10.1007/bf00366918

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  12 in total

Review 1.  Epidemiology of drug resistance: implications for a post-antimicrobial era.

Authors:  M L Cohen
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

2.  Variations in antibiograms and plasmid profiles among multiple isolates of Staphylococcus intermedius from pyoderma in dogs.

Authors:  H C Wegener; K Pedersen
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

Review 3.  Epidemiology and mechanisms of antimicrobial resistance.

Authors:  M F Parry
Journal:  Am J Infect Control       Date:  1989-10       Impact factor: 2.918

4.  Small antibiotic resistance plasmids in Staphylococcus intermedius.

Authors:  R T Greene; S Schwarz
Journal:  Zentralbl Bakteriol       Date:  1992-02

5.  New considerations for rational antibiotic therapy of cutaneous staphylococcal infection in the dog.

Authors:  G A Kunkle
Journal:  Semin Vet Med Surg Small Anim       Date:  1987-08

6.  Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs.

Authors:  K Küng; J L Riond; M Wanner
Journal:  J Vet Pharmacol Ther       Date:  1993-12       Impact factor: 1.786

7.  Common antibiotic resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis from human and canine infections.

Authors:  S Schwarz; M Cardoso; S Grölz-Krug; H Blobel
Journal:  Zentralbl Bakteriol       Date:  1990-08

8.  Antibodies to staphylococcal DNases in sera from different animal species, including humans.

Authors:  S Høie; K Fossum
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

9.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

10.  Enterotoxigenicity of Staphylococcus intermedius of canine origin.

Authors:  E Y Hirooka; E E Müller; J C Freitas; E Vicente; Y Yoshimoto; M S Bergdoll
Journal:  Int J Food Microbiol       Date:  1988-12       Impact factor: 5.277

View more
  5 in total

1.  Antimicrobial drug use and resistance in dogs.

Authors:  John F Prescott; W J Brad Hanna; Richard Reid-Smith; Kelli Drost
Journal:  Can Vet J       Date:  2002-02       Impact factor: 1.008

2.  Antimicrobial resistance in Staphylococcus spp., Escherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermatological disorders, compared with non-treated control dogs.

Authors:  M Rantala; E Lahti; J Kuhalampil; S Pesonen; A K Järvinen; T Honkanen-Buzalski
Journal:  Acta Vet Scand       Date:  2004       Impact factor: 1.695

3.  Antibacterial drugs prescribed for dogs and cats in Sweden and Norway 1990-1998.

Authors:  K Odensvik; K Grave; C Greko
Journal:  Acta Vet Scand       Date:  2001       Impact factor: 1.695

4.  Antimicrobial resistance and characterisation of staphylococci isolated from healthy Labrador retrievers in the United Kingdom.

Authors:  Vanessa M Schmidt; Nicola J Williams; Gina Pinchbeck; Caroline E Corless; Stephen Shaw; Neil McEwan; Susan Dawson; Tim Nuttall
Journal:  BMC Vet Res       Date:  2014-01-14       Impact factor: 2.741

Review 5.  Methicillin-resistant Staphylococcus aureus colonization and infection risks from companion animals: current perspectives.

Authors:  Efthimia Petinaki; Iris Spiliopoulou
Journal:  Vet Med (Auckl)       Date:  2015-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.